By April 15, this could trigger a $12 billion explosion

One tiny cannabis startup

Please do not reply to this message, as replies are routed to an unmonitored mailbox. You are receiving this email as a part of your subscription to Cannabis Profits Daily. If you have any questions or would like to change free your email settings, please reference the contact information at the bottom of this email.

By April 15, This Could Trigger a $12 BILLION Explosion There's one tiny cannabis startup that just solved a billion-dollar problem. This company is still private - but we've discovered there will be a window of opportunity that will let anyone who wants to invest in the company. This is a once-in-a-lifetime chance to claim a ground-floor opportunity in a company that could make you millions. But if you want a shot at making the biggest gains, you need to act quickly... we expect there could be $12 billion in new wealth at stake before April 15. Here are all the details. CBD at CVS Is a Big Win for This Cannabis Stock A landmark deal just placed CBD inside drug stores across the nation. At the center of this deal is one of our key picks, and it's already taking off on the news. Read more about how cannabis is hitting CVS shelves and what this means for our picks - and the industry as a whole. You don't want to miss this. Critical: We're Watching This Enormous Opportunity in the Marijuana Market The cannabis industry is moving so quickly even its staunchest opponents have come around. Even former Speaker of the House John Boehner is telling Americans to go "all in" - and he's revealing three events set to unleash the profit opportunity of a lifetime. Take a look... The Story Does Not End Here New Jersey politicians couldn't reach an agreement on cannabis legalization, and New York dropped the matter from its budget bill. But that's far from the end of these efforts, and there's even more happening on this side of the nation. See how cannabis legalization is working its way along the East Coast by clicking here... Our Top Picks Don't Make Gimmicky CBD Products More CBD products are hitting the shelves than ever before, but not all products are going to help the cannabis industry to be taken seriously. A recent announcement from a beloved jelly bean manufacturer looks enticing, but it may not be the best thing for this sector. I want to make sure you know how to avoid the pitfalls and make the best investing choices for yourself. See more here. You are receiving this e-mail at its028@gmail.com, as a part of your subscription. Remove your email from this list: Unsubscribe © 2019 The National Institute for Cannabis Investors All Rights Reserved The National Institute for Cannabis Investors | 1125 N Charles Street | Baltimore, MD 21201 Toll Free: 866.260.0361; International: 410.777.8270 Contact Customer Service Website: https://nicinvestors.com Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers. All of our employees and agents must wait 24 hours after on-line publication or 72 hours after the mailing of printed-only publication prior to following an initial recommendation. Any investments recommended in this letter should be made only after consulting with your financial adviser and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. This information may only be used pursuant to the subscription agreement and any reproduction, copying, or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The National Institute for Cannabis Investors, 1125 N Charles Street, Baltimore, MD 21201. Privacy Policy | Terms & Conditions